Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 9 studies | 75% ± 17% | |
| retinal rod cell | 9 studies | 60% ± 21% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 6 studies | 42% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 99% | 23.76 | 179 / 180 | 2% | 0.06 | 9 / 430 |
| skin | 94% | 16.12 | 1699 / 1809 | 4% | 0.11 | 20 / 472 |
| uterus | 93% | 13.53 | 158 / 170 | 0% | 0.00 | 1 / 459 |
| lung | 89% | 11.22 | 514 / 578 | 2% | 0.04 | 21 / 1155 |
| prostate | 89% | 9.99 | 219 / 245 | 0% | 0.01 | 2 / 502 |
| adrenal gland | 90% | 9.96 | 231 / 258 | 0% | 0 | 0 / 230 |
| esophagus | 87% | 9.26 | 1252 / 1445 | 3% | 0.03 | 5 / 183 |
| thymus | 89% | 9.35 | 583 / 653 | 0% | 0 | 0 / 605 |
| bladder | 86% | 9.00 | 18 / 21 | 2% | 0.07 | 9 / 504 |
| blood vessel | 87% | 10.69 | 1160 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 84% | 8.20 | 814 / 966 | 2% | 0.04 | 8 / 527 |
| breast | 84% | 9.63 | 387 / 459 | 1% | 0.05 | 14 / 1118 |
| brain | 85% | 17.33 | 2243 / 2642 | 0% | 0.02 | 3 / 705 |
| adipose | 84% | 8.95 | 1008 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 83% | 8.18 | 200 / 241 | 0% | 0 | 0 / 0 |
| kidney | 82% | 10.01 | 73 / 89 | 0% | 0.03 | 4 / 901 |
| muscle | 82% | 8.13 | 656 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 71% | 5.93 | 234 / 328 | 1% | 0.01 | 1 / 178 |
| stomach | 68% | 5.43 | 244 / 359 | 2% | 0.08 | 7 / 286 |
| heart | 59% | 5.01 | 508 / 861 | 0% | 0 | 0 / 0 |
| liver | 54% | 3.26 | 121 / 226 | 0% | 0 | 0 / 406 |
| peripheral blood | 23% | 4.19 | 216 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 23% | 9.79 | 18 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0001508 | Biological process | action potential |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008076 | Cellular component | voltage-gated potassium channel complex |
| GO_0016020 | Cellular component | membrane |
| GO_0005249 | Molecular function | voltage-gated potassium channel activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | KCNV2 |
| Protein name | Potassium voltage-gated channel subfamily V member 2 (Voltage-gated potassium channel subunit Kv8.2) |
| Synonyms | |
| Description | FUNCTION: Potassium channel subunit. Modulates channel activity by shifting the threshold and the half-maximal activation to more negative values. |
| Accessions | Q8TDN2 ENST00000382082.4 |